1 Min Read
Nov 7 (Reuters) - Biocon Ltd
* Says mylan resubmits Biosimilar Trastuzumab and Pegfilgrastim dosseirs with EMA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.